Hepatosplenic T-cell lymphoma: a rare but challenging entity.
Pro B, Allen P, Behdad A.
Blood. 2020 Oct 29;136(18):2018-2026. doi: 10.1182/blood.2019004118.
Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D, De Leval L, Michiels S, Wittnebel S; EuroBloodNet for rare diseases.
Curr Opin Oncol. 2021 Sep 1;33(5):406-411. doi: 10.1097/CCO.0000000000000775.
Hepatosplenic T-cell lymphoma in children and adolescents.
Schwartz LF, Devine KJ, Xavier AC.
Blood Adv. 2025 Apr 22;9(8):1847-1858. doi: 10.1182/bloodadvances.2025015857.
Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M, Miranda RN, Medeiros LJ.
Hum Pathol. 2018 Apr;74:5-16. doi: 10.1016/j.humpath.2018.01.005. Epub 2018 Jan 11.
Hepatosplenic T-Cell Lymphomas.
Gowda L, Foss F.
Cancer Treat Res. 2019;176:185-193. doi: 10.1007/978-3-319-99716-2_9.
Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ, Govi S, Pileri SA.
Crit Rev Oncol Hematol. 2012 Aug;83(2):283-92. doi: 10.1016/j.critrevonc.2011.10.001. Epub 2011 Nov 1.
Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A, Prindiville T.
J Crohns Colitis. 2010 Nov;4(5):511-22. doi: 10.1016/j.crohns.2010.05.006. Epub 2010 Jun 25.
Hepatosplenic gammadelta T-cell lymphoma: an overview.
Visnyei K, Grossbard ML, Shapira I.
Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):360-9. doi: 10.1016/j.clml.2013.03.011.
Hepatosplenic gamma-delta T-Cell Lymphoma: Who Is on Your Speed Dial?
Krishnan M, Lunning M.
J Oncol Pract. 2019 Jun;15(6):307-312. doi: 10.1200/JOP.18.00594.
Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity.
Gabra A, Polanco J, Thapa S, Sawhney S, Glazyrin A.
J Hematol. 2024 Apr;13(1-2):29-33. doi: 10.14740/jh1203. Epub 2024 Apr 9.
